Back to Awarded Treatment Trials
Awarded Trial: 03T-352
Grant ID
03T-352
Illness
Schizophrenia
Primary Drug/Intervention
Amisulpride and Quetiapine
Primary Dosage
<= 1200mg and <=800mg
Secondary Drug Intervention
Clozapine
Secondary Dosage
<= 900 mg
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Haro
Sample Size
62
Duration of Study Period for Each Subject
24 weeks
Outcome Measurements
PANSS, CGI, GAF, AIMS, Living Skills Profile, Simpson Scale (modified for akathisia)
Results
Because of recruitment problems, only 27 patients were studied. There was virtually no difference between the two groups on any measure after 24 weeks.
Publication
N/A
Link
N/A
PI Name
Josep Haro
Degree
MD
Center
Mental Health Services
Institution
Sant Joan de Deu
Address
Carrer Santa Rosa, 39 - 57, 4a planta
City or Town
Barcelona
State or Province
N/A
Zip or Postal Code
8950
Country
Spain
Email Address
jmharo@fsjd.org